Literature DB >> 24080693

Neurodegenerative diseases: New kinase targets for Alzheimer's disease.

Monica Hoyos Flight.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24080693     DOI: 10.1038/nrd4132

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.

Authors:  Mathéa Pietri; Caroline Dakowski; Samia Hannaoui; Aurélie Alleaume-Butaux; Julia Hernandez-Rapp; Audrey Ragagnin; Sophie Mouillet-Richard; Stéphane Haik; Yannick Bailly; Jean-Michel Peyrin; Jean-Marie Launay; Odile Kellermann; Benoit Schneider
Journal:  Nat Med       Date:  2013-08-18       Impact factor: 53.440

2.  Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits.

Authors:  Tao Ma; Mimi A Trinh; Alyse J Wexler; Clarisse Bourbon; Evelina Gatti; Philippe Pierre; Douglas R Cavener; Eric Klann
Journal:  Nat Neurosci       Date:  2013-08-11       Impact factor: 24.884

  2 in total
  2 in total

Review 1.  Alzheimer's disease and chronic traumatic encephalopathy: Distinct but possibly overlapping disease entities.

Authors:  Ryan C Turner; Brandon P Lucke-Wold; Matthew J Robson; John M Lee; Julian E Bailes
Journal:  Brain Inj       Date:  2016-08-11       Impact factor: 2.311

Review 2.  Influenza Virus Infections and Cellular Kinases.

Authors:  Robert Meineke; Guus F Rimmelzwaan; Husni Elbahesh
Journal:  Viruses       Date:  2019-02-20       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.